Lemaitre W. George's most recent trade in Lemaitre Vascular Inc was a trade of 12 Dividend Equivalent Rights done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 12 | 24 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 11 | 50 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 9 | 48 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7 | 67 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 7 | 67 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 49 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 2 | 46 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 85.86 per share. | 16 May 2025 | 71,168 | 1,802,483 (9%) | 0% | 85.9 | 6,110,178 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 84.77 per share. | 16 May 2025 | 18,733 | 1,873,651 (9%) | 0% | 84.8 | 1,587,923 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 7,836 | 7,836 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 16 May 2025 | 7,836 | 1,810,411 (9%) | 0% | 37.3 | 292,204 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 7,734 | 7,733 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.60 per share. | 16 May 2025 | 7,734 | 1,818,145 (9%) | 0% | 48.6 | 375,872 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 7,075 | 16,269 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.19 per share. | 16 May 2025 | 7,075 | 1,825,220 (9%) | 0% | 47.2 | 333,869 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 6,182 | 20,373 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.65 per share. | 16 May 2025 | 6,182 | 1,831,402 (9%) | 0% | 54.6 | 337,846 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 5,792 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 16 May 2025 | 5,792 | 1,802,575 (9%) | 0% | 35.5 | 205,500 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 84.94 per share. | 16 May 2025 | 5,700 | 1,796,783 (8%) | 0% | 84.9 | 484,155 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 85.24 per share. | 16 May 2025 | 3,300 | 1,828,102 (9%) | 0% | 85.2 | 281,297 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 84.69 per share. | 16 May 2025 | 1,099 | 1,827,003 (9%) | 0% | 84.7 | 93,077 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 11 | 11 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 10 | 39 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 9 | 39 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 7 | 59 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 7 | 60 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 46 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 2 | 43 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 1,510 | 1,892,820 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.85 per share. | 28 Feb 2025 | 447 | 1,892,384 (9%) | 0% | 91.9 | 41,057 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 11 | 28 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 11 | 1,892,831 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lemaitre W. George | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.12 per share. | 20 Dec 2024 | 482 | 1,891,310 (9%) | 0% | 92.1 | 44,402 | Common Stock |
| Lemaitre Vascular Inc | W. George Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 53 | 1,891,792 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | W. George Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 53 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 658 | 1,892,397 (9%) | 0% | 100.3 | 65,984 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 658 | 1,891,739 (9%) | 0% | 100.3 | 65,984 | Common Stock |
| Lemaitre Vascular Inc | W. Lemaitre George | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 11 Dec 2024 | 647 | 1,893,003 (9%) | 0% | 101 | 65,347 | Common Stock |
| Lemaitre Vascular Inc | Lemaitre George W. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 40 | 42 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 40 | 1,893,650 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lemaitre George W. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 26 | 52 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | W. Lemaitre George | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 26 | 1,893,029 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lemaitre George W. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 26 | 1,893,055 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | W. George Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 26 | 53 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 28,377 | 28,377 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 4,945 | 1,894,133 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 7 | 39 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 6 | 79 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 6 | 78 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 4 | 82 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 1 | 54 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 1 | 41 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.47 per share. | 02 Dec 2024 | 298 | 1,889,188 (9%) | 0% | 105.5 | 31,430 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 32 | 39 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 32 | 1,889,486 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.03 per share. | 22 Nov 2024 | 2,818 | 1,889,454 (9%) | 0% | 39.0 | 109,987 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,818 | 5,792 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2024 | 14,320 | 1,886,636 (9%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 9 | 31 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 8 | 71 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 8 | 72 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 5 | 78 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3 | 71 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 1 | 53 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 86.69 per share. | 16 Jul 2024 | 57,372 | 1,900,956 (9%) | 0% | 86.7 | 4,973,791 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 86.27 per share. | 12 Jul 2024 | 27,030 | 1,958,328 (9%) | 0% | 86.3 | 2,331,908 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 86.07 per share. | 12 Jul 2024 | 12,976 | 1,985,358 (9%) | 0% | 86.1 | 1,116,844 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10 | 22 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8 | 64 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8 | 63 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 5 | 73 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 68 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 2 | 51 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 76.80 per share. | 13 May 2024 | 40,968 | 1,998,334 (9%) | 0% | 76.8 | 3,146,371 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 76.42 per share. | 13 May 2024 | 35,826 | 2,043,302 (10%) | 0% | 76.4 | 2,737,687 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2024 | 4,000 | 2,039,302 (10%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 75.23 per share. | 06 May 2024 | 29,500 | 2,149,628 (10%) | 0% | 75.2 | 2,219,309 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 75.24 per share. | 06 May 2024 | 26,044 | 2,107,384 (10%) | 0% | 75.2 | 1,959,522 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 76.12 per share. | 06 May 2024 | 23,206 | 2,179,128 (10%) | 0% | 76.1 | 1,766,466 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 75.86 per share. | 06 May 2024 | 20,256 | 2,087,128 (10%) | 0% | 75.9 | 1,536,539 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 75.94 per share. | 06 May 2024 | 16,200 | 2,133,428 (10%) | 0% | 75.9 | 1,230,238 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 75.30 per share. | 06 May 2024 | 8,000 | 2,079,128 (10%) | 0% | 75.3 | 602,427 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 12 | 12 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 10 | 54 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 10 | 55 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 6 | 67 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 4 | 64 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 2 | 49 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 7,733 | 15,467 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.60 per share. | 22 Mar 2024 | 7,733 | 2,202,334 (11%) | 0% | 48.6 | 375,824 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.19 per share. | 22 Mar 2024 | 7,075 | 2,194,601 (10%) | 0% | 47.2 | 333,869 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 7,075 | 23,344 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 67.95 per share. | 29 Feb 2024 | 32,800 | 2,191,326 (10%) | 0% | 68.0 | 2,228,760 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 69.69 per share. | 29 Feb 2024 | 20,575 | 2,261,721 (11%) | 0% | 69.7 | 1,433,872 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 68.04 per share. | 29 Feb 2024 | 20,200 | 2,225,076 (11%) | 0% | 68.0 | 1,374,408 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 67.51 per share. | 29 Feb 2024 | 15,869 | 2,245,276 (11%) | 0% | 67.5 | 1,071,316 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.14 per share. | 29 Feb 2024 | 5,984 | 2,255,737 (11%) | 0% | 70.1 | 419,718 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 5,828 | 2,261,563 (11%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 68.68 per share. | 29 Feb 2024 | 3,800 | 2,187,526 (10%) | 0% | 68.7 | 260,984 | Common Stock |
| Lemaitre Vascular Inc | George W. Lemaitre | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 68.37 per share. | 29 Feb 2024 | 1,300 | 2,282,296 (11%) | 0% | 68.4 | 88,881 | Common Stock |